Heska Corporation Overview
Pro stress-test →Heska sells, manufactures, markets, and supports diagnostic and specialty products and solutions for veterinary practitioners, including point-of-care diagnostic laboratory instruments, consumables, digital cytology services, practice information management software, reference laboratory testing, allergy testing and immunotherapy, and heartworm preventive products. The company's primary focus is supporting companion animal veterinarians in providing care to their patients.
Strategic Profile
Pro stress-test →Heska was acquired by Mars, Incorporated in April 2023 for $120.00 per share, positioning the diagnostics innovator within Mars Petcare's global veterinary services network. The combination broadens access to diagnostics and technology, accelerates R&D and innovation, and better serves veterinary professionals and pets.
Competitive Landscape
Pro stress-test →Heska competes in veterinary point-of-care diagnostics alongside legacy reference laboratory providers and emerging specialty diagnostic platforms. Key competitors include Zoetis (Abaxis point-of-care systems), IDEXX Laboratories (dominant reference lab and POC diagnostics), and regional European providers. Mars's ownership provides significant competitive advantages through scale, distribution, and integrated pet healthcare services.
Industry Context
Heska Corporation operates in Veterinary point-of-care diagnostics.
Key facts
Founded: 1988 · Headquarters: Loveland, United States · Employees: 1,200+ · Revenue: Estimated $300M-$400M (as of 2022, pre-acquisition) · Market cap: N/A